What are the opening hours?

Monday 8am - 5pm Tuesday 8am - 5pm Wednesday 8am - 5pm Thursday 8am - 5pm Friday 8am - 5pm

IGeneX

IGeneX, Inc. is a reference laboratory specializing in state-of-the-art clinical and research testing for Lyme Disease and Associated Tick-borne Diseases.

IGeneX Inc. has been offering specialty clinical and research testing for Lyme Disease and other associated Tick-borne Diseases since 1991. We provide personalized service to private practice physicians, hospitals and other clinical reference laboratories throughout the world. Our highly trained staff is committed to the following ideals:
● State-of-the-art testing methodology
● Rapid turn-around-

time
● Dedication to personalized testing
● Willingness and availability to answer your diagnostic questions
● Ongoing refinement of existing tests, and
● Research and development for innovative quality tests to enhance your diagnostic tools. We pride ourselves on accuracy and maintain numerous licenses and certifications including: CLIA, Medicare, CA State Department of Health, FL State Department of Health, MD State Department of Health, NY State Department of Health, PA State Department of Health, and NPI. We offer testing for Tick-borne Diseases such as: Lyme Disease, Bartonellosis, Babesiosis, Ehrlichiosis, Anaplasmosis, and Rickettsiosis. Our testing methodologies include: ELISA, Western Blot, PCR, IFA, FISH, Lyme Dot Blot Assay, and Immunoblot Assay. For more information on specific tests and panels that we offer and how to order visit our website: www.igenex.com

09/02/2026

IGeneX will be exhibiting at the ILADS Scientific Conference in Washington, D.C., October 22–25, 2026. As the most focused Lyme and tick-borne disease conference of the year, it's the perfect opportunity to learn about the latest advances in diagnostics and connect with the IGeneX team. Be sure to stop by our booth!

09/01/2026

Longtime IGeneX physician and Lyme disease pioneer, Dr. Richard Horowitz, MD, will give a free 45-minute webinar featuring a sneak peek into his upcoming book, Ending Chronic Illness. He’ll explore the principles behind the MSIDS model, a framework he developed to identify the multiple factors that may contribute to persistent disease. He’ll also highlight drivers of chronic illness that may go unrecognized in standard medical evaluations and provide practical guidance on when and how to use IGeneX testing when tick-borne infection is suspected. Register at igenex.com.

08/12/2026

Watch the replay for Dr. Joseph Burrascano Jr. and Dr. Geoff Dow as they review the clinical presentation and diagnosis of babesiosis, discuss current diagnostic strategies, and share clinical updates on tafenoquine, including its potential role in the management of this important Lyme disease co-infection.

This can be found on the IGeneX website under the Resources tab, Webinars 🖥️

08/05/2026

Join today, Dr. Joseph Burrascano Jr. and Dr. Geoff Dow as they review the clinical presentation and diagnosis of babesiosis, discuss current diagnostic strategies, and share clinical updates on tafenoquine, including its potential role in the management of this important Lyme disease co-infection.

Today, August 5th, 2026
3PM PT / 6PM ET
(Limited space available)

https://us02web.zoom.us/webinar/register/WN_P2gTxidWSh6eD7xdmJcJZw #/registration

08/04/2026

Join Dr. Joseph Burrascano Jr. and Dr. Geoff Dow as they review the clinical presentation and diagnosis of babesiosis, discuss current diagnostic strategies, and share clinical updates on tafenoquine, including its potential role in the management of this important Lyme disease co-infection.

August 5th, 2026
3PM PT / 6PM ET
(Limited space available)

https://us02web.zoom.us/webinar/register/WN_P2gTxidWSh6eD7xdmJcJZw #/registration

08/03/2026

Babesia has been found in all 50 states, although it is most commonly found in the upper Midwest and Northeast parts of the U.S., along with some places in Europe and Canada. Although less common, other cases have been reported in Asia, Africa, South America, and Australia.

https://igenex.com/tick-talk/different-types-of-babesia/

07/15/2026

: New research published in Microbiology Spectrum shows FDA-cleared single-step immunoblot IGeneX tests can improve early detection of .

In a study of more than 1,100 serum samples, IGeneX tests detected antibodies in 58.3% of early Lyme disease cases compared to 30.0% with standard two-tier testing, highlighting the potential to support earlier diagnosis and treatment.

Learn more here: https://bit.ly/4w0DlGA

06/19/2026

IGeneX and the American Clinical Laboratory Association (ACLA) thank the 100+ bipartisan, bicameral cosponsors of the . This milestone marks significant progress in the effort to protect patient access to essential clinical laboratory testing services.

Clinical laboratories play a vital role in patient care by providing critical information that guides disease prevention, diagnosis, treatment, and ongoing management. The RESULTS Act would help modernize Medicare's laboratory payment system and provide greater stability for laboratories serving patients nationwide.

You can help. Contact your member of Congress and urge them to support the RESULTS Act and prevent further Medicare cuts to clinical laboratory testing. Visit StopLabCuts.org for more information.

06/12/2026

IGeneX was proud to be a sponsor at the LymeAid fundraiser recently. LymeAid--organized by the Bay Area Lyme Foundation--brings together scientists, clinicians, patients, philanthropists, and supporters to advance the fight against Lyme disease and other tick-borne illnesses. LymeAid raises critical funds that support groundbreaking research, improved diagnostic tools, prevention programs, clinical trials, and grants for emerging researchers. 100% of contributions are directed to the Foundation’s scientific research and prevention initiatives, helping accelerate progress toward making Lyme disease easier to diagnose, more effective to treat, and ultimately curable.

05/31/2026

Remember, while early detection makes a difference, it is never too late to suspect a tick-borne illness as the cause of your unexplained symptoms. We hope the information we have provided throughout this month has left you feeling prepared for the core summer months ahead.

Address

556 Gibraltar Drive
Milpitas, CA
95035

Opening Hours

Monday	8am - 5pm
Tuesday	8am - 5pm
Wednesday	8am - 5pm
Thursday	8am - 5pm
Friday	8am - 5pm

Website

https://igenex.com/

Alerts

Be the first to know and let us send you an email when IGeneX posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your business to be the top-listed Health & Beauty Business in Milpitas?